Who owns Telomir Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TELO from SEC Form 13F filings across 26 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 26 institutions disclosed 3.2M shares of Telomir Pharmaceuticals, Inc. worth $3.9M — about 4.7% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
26
13F holders
$3.9M
value, 2026 filers
4.7%
of shares outstanding (3.2M sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TELO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $1.9M | 0.0% | 2.3% | 0.0% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 438,260 | $526,054 | 0.0% | 0.6% | +29.3% |
| 3 | BlackRock, Inc. | 364,381 | $437,257 | 0.0% | 0.5% | +29.9% |
| 4 | VANGUARD FIDUCIARY TRUST CO | 282,291 | $338,749 | 0.0% | 0.4% | +25.3% |
| 5 | CITADEL ADVISORS LLC | 146,425 | $175,710 | 0.0% | 0.2% | +1003.8% |
| 6 | NORTHERN TRUST CORP | 104,894 | $125,873 | 0.0% | 0.2% | +70.5% |
| 7 | STATE STREET CORP | 58,600 | $70,320 | 0.0% | 0.1% | 0.0% |
| 8 | Bank of New York Mellon Corp | 51,454 | $61,744 | 0.0% | 0.1% | 0.0% |
| 9 | CAPTRUST FINANCIAL ADVISORS | 51,194 | $61,433 | 0.0% | 0.1% | 0.0% |
| 10 | OSAIC HOLDINGS, INC. | 30,990 | $36,962 | 0.0% | 0% | -25.3% |
| 11 | Praetorian Wealth Management, Inc. | 20,000 | $24,000 | 0.0% | 0% | 0.0% |
| 12 | OneDigital Investment Advisors LLC | 14,500 | $17,400 | 0.0% | 0% | -37.0% |
| 13 | Morton Capital Management LLC/CA | 12,658 | $15,190 | 0.0% | 0% | 0.0% |
| 14 | Clearstead Advisors, LLC | 12,530 | $15,036 | 0.0% | 0% | 0.0% |
| 15 | REGIONS FINANCIAL CORP | 10,638 | $12,766 | 0.0% | 0% | 0.0% |
| 16 | UBS Group AG | 7,170 | $8,604 | 0.0% | 0% | -9.9% |
| 17 | Vanguard Global Advisers, LLC | 6,552 | $7,862 | 0.0% | 0% | 0.0% |
| 18 | Nuveen, LLCNEW | 2,996 | $3,745 | 0.0% | 0% | new |
| 19 | Tower Research Capital LLC (TRC) | 2,316 | $2,779 | 0.0% | 0% | -70.8% |
| 20 | ROYAL BANK OF CANADA | 1,341 | $2,000 | 0.0% | 0% | +77.9% |
| 21 | FMR LLCNEW | 710 | $852 | 0.0% | 0% | new |
| 22 | JONES FINANCIAL COMPANIES LLLP | 600 | $738 | 0.0% | 0% | 0.0% |
| 23 | BNP PARIBAS FINANCIAL MARKETS | 201 | $241 | 0.0% | 0% | 0.0% |
| 24 | JPMORGAN CHASE & CO | 121 | $142 | 0.0% | 0% | 0.0% |
| 25 | GK Wealth Management LLCNEW | 100 | $120 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.